BCL2L13 and metabolic disease: On this basis, a more in‐depth investigation of the specific mechanisms of FKBP8 and BCL2L13‐related mitophagy pathways in MS‐related metabolic diseases such as IR and T2DM can help to understand the role of mitophagy in MS more comprehensively and thorough.